Cybersecurity in GxP Environments: Protecting Data Integrity and Product Supply

A cyber incident in a pharmaceutical company is not only an IT problem. It can stop production, compromise records, delay batch release and interrupt medicine supply. Quality and IT therefore need a shared view of security in the GxP landscape.

Where security and GxP meet

Annex 11 requires physical and logical controls for access, requires incidents to be reported and assessed, and expects business continuity arrangements for system failure. These expectations map neatly onto information security practice. A cyber attack that corrupts or encrypts data also threatens the integrity and availability of GMP records, so the incident process should connect to quality management, including deviation handling and impact assessment on released and in-process batches.

Security as part of the validated state

Security controls should be considered when systems are specified, not added later. Practical elements include:

  • Network segmentation, particularly between corporate IT and production or laboratory systems
  • Patch and vulnerability management with risk-based timelines, routed through change control
  • Malware protection and control of removable media on validated and standalone systems
  • Supplier and remote-access governance, with logging of vendor sessions
  • Tested, protected backups held separately from the production network

The regulatory landscape is widening

Beyond GMP, the NIS2 Directive (Directive (EU) 2022/2555) sets cybersecurity risk management and incident reporting obligations for entities in sectors it covers, and applicability to a particular company depends on national transposition and the company’s size and activities. Check your position with legal advice rather than assuming. Standards such as ISO/IEC 27001 offer a recognised framework to organise controls.

Rehearse the bad day

Plans only help if they have been exercised. Run a scenario in which the main systems are unavailable: how are batches handled, how are paper records controlled and reconciled afterwards, who makes the call on release, and who informs authorities if medicine supply is at risk? Document the exercise and its lessons, and feed them into the next periodic review.

What good looks like

A mature approach has a current inventory, risk-based validation proportionate to impact, controlled changes, reviewed audit trails, tested recovery and an honest register of known limitations with owners and dates. It does not require perfection, but it does require that the organisation knows its own position better than an inspector can discover it in a few days.

How PQRA helps

PQRA can help bridge quality and IT by assessing security controls on GxP systems against Annex 11 and data integrity expectations, aligning incident management with deviation and batch impact assessment, and supporting business continuity exercises. For wider information security programmes we can also help prepare for ISO/IEC 27001.

Contact PQRA to discuss your computerised systems and data governance programme.

CATEGORIES:

Uncategorized

Tags:

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *